A framework for cost-sharing policy analysis
To assess the effect of cost sharing, a framework for describing and evaluating cost-sharing programmes was constructed, followed by a comprehensive search of the international literature on the subject. The results indicated that cost sharing carries many potential advantages, one of which includes...
Gespeichert in:
| Veröffentlicht in: | PharmacoEconomics 1996, Vol.10 Suppl 2, p.56-67 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 67 |
|---|---|
| container_issue | |
| container_start_page | 56 |
| container_title | PharmacoEconomics |
| container_volume | 10 Suppl 2 |
| creator | Rubin, R J Mendelson, D N |
| description | To assess the effect of cost sharing, a framework for describing and evaluating cost-sharing programmes was constructed, followed by a comprehensive search of the international literature on the subject. The results indicated that cost sharing carries many potential advantages, one of which includes increased consumer attention to healthcare costs. However, proper design of cost-sharing programmes is necessary to mitigate regressivity and other common problems associated with many current programmes. These findings should help policy makers to understand and anticipate the effects of cost sharing, and to create innovative benefit design solutions that are targeted to promote health system goals. |
| doi_str_mv | 10.2165/00019053-199600102-00010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78360428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78360428</sourcerecordid><originalsourceid>FETCH-LOGICAL-p238t-245a8da4ad3ec3550397cfeedcf1500e9cc90eb5758c37963316ce772807a9f43</originalsourceid><addsrcrecordid>eNo1j7FOwzAURT2AaCn8AvLEhOHZL7bjsaqgIFVigTlyHRsCSRzsRKh_TxBluldHR1e6hFAOt4IreQcA3IBExo1RcwfBfhGckCXnGphWBhbkPOePGSvU4owsOHCFBeoluVnTkGznv2P6pCEm6mIeWX63qenf6BDbxh2o7W17yE2-IKfBttlfHnNFXh_uXzaPbPe8fdqsd2wQWI5MFNKWtS1sjd6hlIBGu-B97QKXAN44Z8DvpZalQ20UIlfOay1K0NaEAlfk-m93SPFr8nmsuiY737a293HKlS5RQSHKWbw6itO-83U1pKaz6VD9_8MfOJZQeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78360428</pqid></control><display><type>article</type><title>A framework for cost-sharing policy analysis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Rubin, R J ; Mendelson, D N</creator><creatorcontrib>Rubin, R J ; Mendelson, D N</creatorcontrib><description>To assess the effect of cost sharing, a framework for describing and evaluating cost-sharing programmes was constructed, followed by a comprehensive search of the international literature on the subject. The results indicated that cost sharing carries many potential advantages, one of which includes increased consumer attention to healthcare costs. However, proper design of cost-sharing programmes is necessary to mitigate regressivity and other common problems associated with many current programmes. These findings should help policy makers to understand and anticipate the effects of cost sharing, and to create innovative benefit design solutions that are targeted to promote health system goals.</description><identifier>ISSN: 1170-7690</identifier><identifier>DOI: 10.2165/00019053-199600102-00010</identifier><identifier>PMID: 10163437</identifier><language>eng</language><publisher>New Zealand</publisher><subject>Cost Sharing - legislation & jurisprudence ; Health Care Costs ; Health Services ; Health technology assessment ; Insurance Benefits ; Program Development ; Program Evaluation</subject><ispartof>PharmacoEconomics, 1996, Vol.10 Suppl 2, p.56-67</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10163437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rubin, R J</creatorcontrib><creatorcontrib>Mendelson, D N</creatorcontrib><title>A framework for cost-sharing policy analysis</title><title>PharmacoEconomics</title><addtitle>Pharmacoeconomics</addtitle><description>To assess the effect of cost sharing, a framework for describing and evaluating cost-sharing programmes was constructed, followed by a comprehensive search of the international literature on the subject. The results indicated that cost sharing carries many potential advantages, one of which includes increased consumer attention to healthcare costs. However, proper design of cost-sharing programmes is necessary to mitigate regressivity and other common problems associated with many current programmes. These findings should help policy makers to understand and anticipate the effects of cost sharing, and to create innovative benefit design solutions that are targeted to promote health system goals.</description><subject>Cost Sharing - legislation & jurisprudence</subject><subject>Health Care Costs</subject><subject>Health Services</subject><subject>Health technology assessment</subject><subject>Insurance Benefits</subject><subject>Program Development</subject><subject>Program Evaluation</subject><issn>1170-7690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j7FOwzAURT2AaCn8AvLEhOHZL7bjsaqgIFVigTlyHRsCSRzsRKh_TxBluldHR1e6hFAOt4IreQcA3IBExo1RcwfBfhGckCXnGphWBhbkPOePGSvU4owsOHCFBeoluVnTkGznv2P6pCEm6mIeWX63qenf6BDbxh2o7W17yE2-IKfBttlfHnNFXh_uXzaPbPe8fdqsd2wQWI5MFNKWtS1sjd6hlIBGu-B97QKXAN44Z8DvpZalQ20UIlfOay1K0NaEAlfk-m93SPFr8nmsuiY737a293HKlS5RQSHKWbw6itO-83U1pKaz6VD9_8MfOJZQeg</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Rubin, R J</creator><creator>Mendelson, D N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>A framework for cost-sharing policy analysis</title><author>Rubin, R J ; Mendelson, D N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p238t-245a8da4ad3ec3550397cfeedcf1500e9cc90eb5758c37963316ce772807a9f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Cost Sharing - legislation & jurisprudence</topic><topic>Health Care Costs</topic><topic>Health Services</topic><topic>Health technology assessment</topic><topic>Insurance Benefits</topic><topic>Program Development</topic><topic>Program Evaluation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rubin, R J</creatorcontrib><creatorcontrib>Mendelson, D N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>PharmacoEconomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rubin, R J</au><au>Mendelson, D N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A framework for cost-sharing policy analysis</atitle><jtitle>PharmacoEconomics</jtitle><addtitle>Pharmacoeconomics</addtitle><date>1996</date><risdate>1996</risdate><volume>10 Suppl 2</volume><spage>56</spage><epage>67</epage><pages>56-67</pages><issn>1170-7690</issn><abstract>To assess the effect of cost sharing, a framework for describing and evaluating cost-sharing programmes was constructed, followed by a comprehensive search of the international literature on the subject. The results indicated that cost sharing carries many potential advantages, one of which includes increased consumer attention to healthcare costs. However, proper design of cost-sharing programmes is necessary to mitigate regressivity and other common problems associated with many current programmes. These findings should help policy makers to understand and anticipate the effects of cost sharing, and to create innovative benefit design solutions that are targeted to promote health system goals.</abstract><cop>New Zealand</cop><pmid>10163437</pmid><doi>10.2165/00019053-199600102-00010</doi><tpages>12</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1170-7690 |
| ispartof | PharmacoEconomics, 1996, Vol.10 Suppl 2, p.56-67 |
| issn | 1170-7690 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78360428 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Cost Sharing - legislation & jurisprudence Health Care Costs Health Services Health technology assessment Insurance Benefits Program Development Program Evaluation |
| title | A framework for cost-sharing policy analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T15%3A50%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20framework%20for%20cost-sharing%20policy%20analysis&rft.jtitle=PharmacoEconomics&rft.au=Rubin,%20R%20J&rft.date=1996&rft.volume=10%20Suppl%202&rft.spage=56&rft.epage=67&rft.pages=56-67&rft.issn=1170-7690&rft_id=info:doi/10.2165/00019053-199600102-00010&rft_dat=%3Cproquest_pubme%3E78360428%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78360428&rft_id=info:pmid/10163437&rfr_iscdi=true |